🔎 Trials Near Me

Почетна › Рак на бели дробови со не-мали клетки › Тенеси › Memphis

Клинички испитувања за Рак на бели дробови со не-мали клетки во Memphis, TN

23 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Memphis (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.

Официјален текст на студијата (англиски)

Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Се регрутираФаза 3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Се регрутираФаза 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07293247

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Се регрутираФаза 3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Се регрутираФаза 3
  • Baptist Cancer Center, Memphis
  • Baptist Clinical Research Institute, Memphis
  • Baptist Cancer Center, Bartlett · на 11 милји
  • и уште 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07144280

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Се регрутираФаза 3
  • Regional One Health, Memphis
Возраст од 18 до 100 · Сите полови · Ажурирано 25.9.2026 · NCT05920356

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Се регрутираФаза 2
  • Research Site, Memphis
Возраст од 18 до 95 · Сите полови · Ажурирано 23.9.2026 · NCT05061550

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Се регрутираФаза 2
  • Baptist Clinical Research Institute, Memphis
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT06745882

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Се регрутираФаза 2/3
  • West Cancer Center & Research Institute - East Campus, Germantown · на 14 милји
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT04613596

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Се регрутираФаза 2
  • Baptist Clinical Research Institute, Memphis
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT04302025

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Се регрутираФаза 3
  • Baptist Memorial Hospital-Memphis, Memphis
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06119581

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Се регрутираФаза 3
  • Research Site, Memphis
Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07291037

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Се регрутираФаза 1
  • The West Clinic, PLLC dba West Cancer Center, Germantown · на 14 милји
Возраст 18 и постари · Сите полови · Ажурирано 29.7.2026 · NCT06764771

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Се регрутираФаза 1/2
  • Baptist Medical Center, Memphis
Возраст 18 и постари · Сите полови · Ажурирано 30.6.2026 · NCT06162221

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Се регрутираФаза 2
  • Baptist Cancer Center, Memphis
Возраст од 18 до 70 · Сите полови · Ажурирано 26.6.2026 · NCT04614103

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Се регрутираФаза 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Возраст 18 и постари · Сите полови · Ажурирано 3.6.2026 · NCT05642572

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Се регрутираФаза 1/2
  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
Возраст 12 и постари · Сите полови · Ажурирано 27.5.2026 · NCT03093116

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Се регрутираФаза 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Возраст 18 и постари · Сите полови · Ажурирано 6.5.2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Се регрутираФаза 2/3
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
Возраст 18 и постари · Сите полови · Ажурирано 5.5.2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Се регрутираФаза 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · на 23 милји
18 Minutes · Сите полови · Ажурирано 5.5.2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Се регрутираНабљудувачка студија
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital for Women, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · на 11 милји
  • и уште 1
Возраст 18 и постари · Сите полови · Ажурирано 17.3.2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Се регрутираНабљудувачка студија
  • Baptist Cancer Center, Memphis
Возраст 18 и постари · Сите полови · Ажурирано 5.2.2026 · NCT05236114

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Се регрутираНабљудувачка студија
  • Massive Bio SYNERGY-AI site, Memphis
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

Испитувања за Рак на бели дробови со не-мали клетки во други градови

Други студии во Memphis

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.